Life Sciences Investment Banking
An experienced team in a vibrant sector.
Raymond James Life Sciences practice provides comprehensive advisory and financing capabilities to innovative businesses in the biotechnology, specialty pharmaceutical and generic pharmaceutical sectors. Companies within the biopharma industry continue to face the disruptive forces that require them to tailor their strategies in the continually evolving business environment. Our team provides our clients with solutions based on our deep relationships with company management teams as well as venture, private equity and public market investors.
Life Sciences Subsector Expertise
- Biotechnology
- Specialty Pharmaceuticals
Senior Banking Team












Transaction History
Transaction history may include a transaction completed by a Raymond James banker while at a former firm.
Recent News
Global Equities
|
January 12, 2023
Raymond James hires Srini Pajjuri as senior semiconductor analyst
Read More about Raymond James hires Srini Pajjuri as senior semiconductor analyst
Investment Banking
|
January 9, 2023
Raymond James continues expansion of Healthcare Investment Banking Practice, hires three senior bankers
Read more about Raymond James continues expansion of Healthcare Investment Banking Practice, hires three senior bankers
Investment Banking
|
January 9, 2023